Outsourced Pharma, Contract Pharmaceutical, CRO, CMO, Pharmaceutical Drug Development Services

FEATURED EDITORIAL

car on winding road-GettyImages-2157089736

Buckle Up. It's A Strategic Drive To Successful Sourcing

Chief Editor Louis Garguilo says we bounce around the word “strategic” like a biopharma basketball. We’ve even got our own league. More professionals in our outsourcing industry include “strategic” in their titles than ever before. Starting with this editorial, he investigates what this exulted approach to working with external partners really means.

The Regulatory Imperative To Improve Environmental And Sustainability Stewardship In Biopharma
How You And Your CDMO Should Leverage Contamination Control Strategies For Competitive Advantage

GUEST COLUMNISTS

Operating And Maintaining Pharmaceutical Gas Distribution Systems
Drug manufacturers face stringent requirements when using gas that comes into direct contact with the product. This guide discusses operation, maintenance, and monitoring of gas systems.
August 2025 — CDMO Opportunities And Threats Report
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
What Biotech Sponsors Should Look For In A CDMO For Sterile Fill/Finish
Choosing the right CDMO partner for a biotech product isn’t about “capacity at a good price”; it’s about a partner with the right mix of technical expertise, regulatory track record, and more.
How AbbVie's Digital Transformation Brought Platform Knowledge Closer
A custom-built digital ecosystem reduced the time spent on documentation in AbbVie's bioprocess development labs by about 70% for some experiment types.
The New FDA Era Of Radical Transparency And Pervasive Oversight
The first half of 2025 has been transformative for biopharmaceutical quality and regulatory affairs, with the FDA leading the charge with four significant changes. Curadian Group's David Grote discusses implications for all four.
A Case Study In Continuous Process Verification
CPV can strengthen the bridge between compliance and continuous improvement. In this scenario, a hypothetical lab sets out to improve process yields and efficiency.
Optimizing Lentiviral Vectors For Allogeneic CAR-T Manufacturing
A group of graduate researchers explored VSV-G affinity chromatography as an alternative to the standard anion exchange chromatography or AEX.
Reliably Predicting Biologics Hotspots From Prior Knowledge
Site-specific post translational modifications can seriously affect a molecules stability, function, and structure. These modifications are commonly called "hotspots."

PHARMA OUTSOURCING WHITE PAPERS

Assessing A Targeted Molecular Method Against Traditional In Vitro Testing For Adventitious Virus Detection
Discover a CHO AOF panel that provides rapid detection of relevant adventitious viral contaminants in bulk harvest material, and explore data showing equivalent sensitivity to the in vitro assay.

Super Short Activated CAR-T Process
Experience the benefits of faster, more effective CAR-T cell production with this innovative three-day short-cycle process, designed to enhance patient treatment outcomes while reducing costs.
Building A Legacy In Sterile Injectables Through Strong CMO Synergy
Examine how a CMO can deliver significant value to drug developers by fostering successful outsourcing relationships, streamlining the path to market, and supporting demands.
Preparing For Disease X: Effective Vaccine Development In The Face Of A Future Pandemic
CDMOs are playing a critical role in the global effort to prepare for future pandemics. Learn how innovative strategies and flexible platforms are helping to ensure a swift and effective response plan.
Nose To Brain (N2B) Drug Delivery – Benefits And Challenges
Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).
Innovation In Filtration
Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.